Replies to post #240976 on Biotech Values

[DewDiligence]

MRK’s Molnupiravir is piling up at pharmacies because demand is so low:

https://endpts.com/covid-19-roundup-despite-treatment-shortages-some-us-pharmacies-report-pile-ups-of-mercks-antiviral/

The federal government has only sent four shipments of Merck’s Covid-19 antiviral molnupiravir (about 400,000 courses in each shipment) nationwide, and already HHS is reporting that some pharmacies are running out of space for the pill because so few people are using it.